Status:
UNKNOWN
Clonidine as Pain Relief During ROP Eye Examinations
Lead Sponsor:
Region Örebro County
Collaborating Sponsors:
Uppsala County Council, Sweden
Conditions:
Retinopathy of Prematurity
Pain, Procedural
Eligibility:
All Genders
5-3 years
Phase:
PHASE4
Brief Summary
Preterm infants are at risk of developing ROP (retinopathy of prematurity), an eye condition that can cause blindness. Preterm infants born before gestation week (GA) 30 are therefor screened regularl...
Detailed Description
Infants born before gestational week (GA) 30 who are cared for in neonatal units at the university hospitals in Örebro and Uppsala, Sweden can be included in the study. According to power calculation...
Eligibility Criteria
Inclusion
- Infants born before 30 weeks gestation, informed consent from parents
Exclusion
- Infants that have received other pain relieving or sedating drugs within 24 hours before the procedure, infants without GI-tube, infants with neurological deficit, infants with known heart arrhythmia, infants with circulatory instability (MAP below GA in weeks)
Key Trial Info
Start Date :
April 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04902859
Start Date
April 25 2022
End Date
December 31 2024
Last Update
May 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barn- och Ungdomskliniken, Universitetssjukhuset
Örebro, Sweden